April 10, 2024- Mayo Clinic and Terasaki Institute for Biomedical Innovation announced a research collaboration centered on improving organ transplant outcomes. Beginning in April 2024, Mayo Clinic biomedical researchers and Terasaki Institute scientists will work together on two core areas: real-time monitoring of donated organ health from procurement to transplant surgery and developing predictive technologies to determine which transplant recipients have a higher likelihood of rejection.
This will be done by creating prognostic signatures and assays for antibody-mediated rejection of organ transplant. These initial projects are expected to take 24 to 30 months to complete.
This latest collaboration is part of Mayo Clinic’s Transforming Transplant initiative, which has the goal of providing organ transplants for everyone who needs one.